Overview

Hepatitis C Virus(HCV) Heart and Lung Study

Status:
Completed
Trial end date:
2019-07-04
Target enrollment:
Participant gender:
Summary
This is a multicenter study in Hepatitis C Virus (HCV) infected adult patients who also have advanced cardiac disease or advanced lung disease.
Phase:
Phase 4
Details
Lead Sponsor:
Duke University
Collaborator:
Gilead Sciences
Treatments:
Ledipasvir
Ledipasvir, sofosbuvir drug combination
Sofosbuvir